The authors make no claims of the accuracy of the information contained
herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this document shall be liable for any special,
consequential, or exemplary damages resulting in whole or part from any
user's use of or reliance upon this material. PLEASE
READ THE DISCLAIMER CAREFULLY BEFORE
ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE
TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.
Usual Diluents
See comments
Standard Dilutions [Amount of drug]
[Infusion volume] [Infusion rate]
Dilute 50 mg vial with 5 ml-sterile water (10mg/ml). Normally given
undiluted.
May add to 25-50ml NS or D5W and infuse over 10-20 min.
[Too rapid administration can cause severe hypotensive and anaphylactoid
reactions. Facilities to treat shock should be available.]
Stability / Miscellaneous
Treatment of heparin overdose: If immediate,
give 1 mg (up to 1.5mg) IV for every 100u of heparin infused in
preceding 2 hours. Give by slow IV injection (50mg over 10 minutes).
Maximum of 50mg in any 10 minute period. May dilute with 25-50ml NS/D5W
and infuse over 10-20 minutes.
Obtain PTT 5-15 minutes after protamine administration.
If 30 minutes to 1 hour have elapsed before starting protamine:
use 0.5 to 0.75 mg/100 u of heparin (in preceding 2 hours).
If > 2 hours have elapsed: use 0.25 to 0.375mg/
100units. Symptoms of overdose of protamine include hypertension, and
possible hemorrhage due to paradoxical anticoagulation with higher
doses (eg > 100mg).
Source: [package insert]
Disclaimer
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER
CAREFULLY
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.